Free Trial

Twist Bioscience (TWST) SEC Filings & 10K Form

Twist Bioscience logo
$28.59 +2.12 (+8.01%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$28.38 -0.21 (-0.73%)
As of 08/22/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Twist Bioscience SEC Filings

DateFilerForm TypeView
08/21/2025
2:10 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
2:16 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
2:16 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
2:17 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
2:19 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
2:25 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
5:11 AM
Artisan Partners Limited Partnership (Filed by)
Twist Bioscience (Subject)
Form SCHEDULE 13G/A
08/04/2025
2:35 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2025
6:21 AM
Twist Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2025
2:12 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2025
3:05 PM
Laponis Adam (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
2:34 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2025
2:12 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2025
2:14 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2025
2:16 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2025
2:18 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
3:05 PM
Cho Dennis (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:05 PM
Green Paula (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:05 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
2:32 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025
2:12 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025
2:28 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2025
2:15 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
2:18 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
2:18 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
2:24 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
2:28 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2025
3:05 PM
Twist Bioscience (Issuer)
WERNER ROBERT F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
2:07 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:28 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:11 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:15 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:16 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:16 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
2:19 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
11:21 AM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
2:18 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
2:22 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
2:30 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
2:31 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:27 AM
Twist Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon Musk’s New Technology (Ad)

Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel

Get the full details on the AI company behind Musk’s next big move.
04/23/2025
2:17 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/09/2025
2:17 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
2:44 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
2:29 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
2:15 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
2:15 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
3:09 PM
Cho Dennis (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
2:16 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
2:21 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
2:17 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
2:14 PM
ARK Investment Management LLC (Filed by)
Twist Bioscience (Subject)
Form SCHEDULE 13G/A
03/06/2025
2:21 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
2:24 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
2:14 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
2:15 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
2:20 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:18 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:09 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:10 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:13 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:13 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
2:13 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2025
4:16 PM
CRANDELL KEITH (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:05 PM
CHAN NELSON C (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:05 PM
CHESS ROBERT (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:05 PM
Starovasnik Melissa A. (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:05 PM
RAGUSA ROBERT P (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:05 PM
JOHANNESSEN JAN (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
2:16 PM
Chess Robert Bruce (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
6:48 AM
STATE STREET CORP (Filed by)
Twist Bioscience (Subject)
Form SCHEDULE 13G
02/03/2025
3:09 PM
Twist Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/03/2025
2:24 PM
Twist Bioscience (Subject)
WERNER ROBERT F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
2:08 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
2:18 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
2:18 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
2:23 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:18 AM
Twist Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:05 PM
Finn Patrick John (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:18 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:05 PM
Laponis Adam (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:21 PM
ARK Investment Management LLC (Filed by)
Twist Bioscience (Subject)
Form SCHEDULE 13G/A
01/10/2025
2:15 PM
Laponis Adam (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
4:45 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:46 PM
Green Paula (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:47 PM
Finn Patrick John (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:47 PM
Cho Dennis (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
11:09 AM
Chess Robert Bruce (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:24 PM
Twist Bioscience (Filer)
Form DEF 14A
01/06/2025
4:24 PM
Twist Bioscience (Filer)
Form ARS
01/03/2025
2:41 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Elon Musk’s New Technology (Ad)

Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel

Get the full details on the AI company behind Musk’s next big move.
01/03/2025
2:26 PM
Finn Patrick John (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
3:55 PM
CHESS ROBERT (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:52 PM
Twist Bioscience (Filer)
Form PRE 14A
12/20/2024
2:39 PM
Green Paula (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
2:16 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
2:16 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:05 PM
Cho Dennis (Reporting)
Twist Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
2:35 PM
Cho Dennis (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
2:25 PM
Leproust Emily M. (Reporting)
Twist Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TWST) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners